![]() |
![]() |
Legal status
Patent expired
(51) | INT.CL. | A61K 31/335 | (2006.01) |
A61K 31/7048 | (2006.01) | ||
A61K 31/365 | (2006.01) | ||
A61P 1/12 | (2006.01) | ||
A61K 45/06 | (2006.01) |
(11) | Number of the document | 2070530 |
(13) | Kind of document | T |
(96) | European patent application number | 09156339.5 |
Date of filing the European patent application | 2005-05-13 | |
(97) | Date of publication of the European application | 2009-06-17 |
(45) | Date of publication and mention of the grant of the patent | 2016-02-17 |
(46) | Date of publication of the claims translation | 2016-05-10 |
(30) | Number | Date | Country code |
570697 P | 2004-05-14 | US |
(72) |
Shue, Youe-Kong, US
Babakhani, Farah Kondori, US
Okumu, Franklin W., US
Sears, Pamela Suzanne, US
Miller-Shangle, Starr Louise, US
Walsh, Robert Brian, US
|
(73) |
Merck Sharp & Dohme LLC,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Ligų, susijusių su antibiotikų vartojimu, gydymas |
Treatment of diseases associated with the use of antibiotics |
Payment date | Validity (years) | Amount | |
2024-04-16 | 347.00 EUR |